Gene therapy holds great promise for treating neurological disorders, but it faces several key challenges:
Blood-Brain Barrier (BBB): The BBB restricts the delivery of therapeutic agents, complicating the transport of gene therapy vectors to the brain.
Cell Targeting: Neurological disorders involve specific neuron types, making precise targeting critical for effective treatment.
Disease Heterogeneity: The diverse nature of neurological disorders complicates the development of one-size-fits-all gene therapies.
Long-Term Effects: The long-term safety and efficacy of gene therapies in the central nervous system (CNS) remain uncertain, requiring extensive research.
Ethical and Regulatory Issues: Stringent regulations ensure safety but can slow the pace of innovation in gene therapy.
Cost and Accessibility: High costs hinder access to these therapies for many patients, necessitating ongoing efforts to improve affordability.
Got more to add on this topic? Share your thoughts in the comments below!
Comments